Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18252785.
- Also identified by DOI 10.1210/jc.2007-2449 and PMC identifier 2291484.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The insulinoma syndrome is marked by fasting hypoglycemia and inappropriate elevations of insulin. The gastrinoma syndrome is characterized by hypergastrinemia, ulcer disease, and/or diarrhea. Rarely, insulinoma and gastrinoma coexist in the same patient simultaneously. Our objective was to determine the cause of a patient's hypoglycemic episodes and peptic ulcer disease. This is a clinical case report from the Clinical Research Center of the National Institutes of Health. One patient with hypoglycemic episodes and peptic ulcer disease had a surgical resection of neuroendocrine tumor. The patient was found to have a single tumor cosecreting both insulin and gastrin. Resection of this single tumor was curative. A single pancreatic neuroendocrine tumor may lead to the expression of both the hyperinsulinemic and hypergastrinemic syndromes.
Medical subject headings
- Gastrinoma
- Insulinoma
- Neuroendocrine Tumors
- Pancreatic Neoplasms